Profound Medical PROF Stock
Profound Medical Price Chart
Profound Medical PROF Financial and Trading Overview
| Profound Medical stock price | 6.55 USD |
| Previous Close | 6.81 USD |
| Open | 6.69 USD |
| Bid | 4.83 USD x 200 |
| Ask | 8.56 USD x 200 |
| Day's Range | 6.67 - 6.85 USD |
| 52 Week Range | 3.76 - 8.95 USD |
| Volume | 55.36K USD |
| Avg. Volume | 182.8K USD |
| Market Cap | 242.37M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.24 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.14 USD |
PROF Valuation Measures
| Enterprise Value | 199.54M USD |
| Trailing P/E | N/A |
| Forward P/E | -8.869681 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.882536 |
| Price/Book (mrq) | 3.6448088 |
| Enterprise Value/Revenue | 10.606 |
| Enterprise Value/EBITDA | -5.305 |
Trading Information
Profound Medical Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 24.04% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 8.95 USD |
| 52 Week Low | 3.76 USD |
| 50-Day Moving Average | 6.58 USD |
| 200-Day Moving Average | 6.32 USD |
PROF Share Statistics
| Avg. Volume (3 month) | 182.8K USD |
| Avg. Daily Volume (10-Days) | 53.83K USD |
| Shares Outstanding | 36.34M |
| Float | 34.84M |
| Short Ratio | 24.72 |
| % Held by Insiders | 4.07% |
| % Held by Institutions | 47.95% |
| Shares Short | 2.19M |
| Short % of Float | 6.80% |
| Short % of Shares Outstanding | 6.01% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -206.75% |
| Operating Margin (ttm) | -150.28% |
| Gross Margin | 71.07% |
| EBITDA Margin | -199.91% |
Management Effectiveness
| Return on Assets (ttm) | -35.46% |
| Return on Equity (ttm) | -70.58% |
Income Statement
| Revenue (ttm) | 18.81M USD |
| Revenue Per Share (ttm) | 0.59 USD |
| Quarterly Revenue Growth (yoy) | 103.60% |
| Gross Profit (ttm) | 13.37M USD |
| EBITDA | -37612000 USD |
| Net Income Avi to Common (ttm) | -38899000 USD |
| Diluted EPS (ttm) | -1.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 50.3M USD |
| Total Cash Per Share (mrq) | 1.38 USD |
| Total Debt (mrq) | 7.46M USD |
| Total Debt/Equity (mrq) | 12.56 USD |
| Current Ratio (mrq) | 6.555 |
| Book Value Per Share (mrq) | 1.83 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -38507000 USD |
| Levered Free Cash Flow (ttm) | -22827124 USD |
Profile of Profound Medical
| Country | United States |
| State | ON |
| City | Mississauga |
| Address | 2400 Skymark Avenue |
| ZIP | L4W 5K5 |
| Phone | 647 476 1350 |
| Website | https://www.profoundmedical.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 162 |
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Q&A For Profound Medical Stock
What is a current PROF stock price?
Profound Medical PROF stock price today per share is 6.55 USD.
How to purchase Profound Medical stock?
You can buy PROF shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Profound Medical?
The stock symbol or ticker of Profound Medical is PROF.
Which industry does the Profound Medical company belong to?
The Profound Medical industry is Medical Devices.
How many shares does Profound Medical have in circulation?
The max supply of Profound Medical shares is 36.34M.
What is Profound Medical Price to Earnings Ratio (PE Ratio)?
Profound Medical PE Ratio is now.
What was Profound Medical earnings per share over the trailing 12 months (TTM)?
Profound Medical EPS is -1.24 USD over the trailing 12 months.
Which sector does the Profound Medical company belong to?
The Profound Medical sector is Healthcare.
Profound Medical PROF included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Capital Market Composite RCMP | 148.96 USD — |
-1.84
|
— — | 148.23 USD — | 151.02 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}